for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Straumann Holding AG

STMN.S

Latest Trade

1,350.00CHF

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

670.60

 - 

1,391.00

As of on the SIX Swiss Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,350.00
Open
--
Volume
--
3M AVG Volume
0.69
Today's High
--
Today's Low
--
52 Week High
1,391.00
52 Week Low
670.60
Shares Out (MIL)
15.89
Market Cap (MIL)
21,156.08
Forward P/E
57.55
Dividend (Yield %)
0.43

Next Event

Straumann Holding AG at Kepler Cheuvreux SA Roadshow - Nordics (Virtual)

Latest Developments

More

Straumann Holding Raises 2021 Revenue Guidance

Straumann To Invest Up To 1.2 Billion Chinese Yuan In Its China Campus

Straumann Q4 Revenue At CHF 1.4 Billion

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Straumann Holding AG

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

Industry

Medical Equipment & Supplies

Contact Info

Peter Merian-Weg 12

4002

Switzerland

+41.61.9651111

https://www.straumann.com/

Executive Leadership

Gilbert Achermann

Non-Executive Chairman of the Board

Guillaume Daniellot

Chief Executive Officer, Member of the Executive Management Board

H. C. Thomas Straumann

Non-Executive Vice Chairman of the Board of Directors

Peter Hackel

Chief Financial Officer, Member of the Executive Management Board

Mark Johnson

Member of the Executive Management Board, Head Research, Development & Operations

Key Stats

2.47 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, CHF)

2018

1.4K

2019

1.6K

2020

1.4K

2021(E)

1.8K
EPS (CHF)

2018

16.940

2019

21.200

2020

16.160

2021(E)

23.110
Price To Earnings (TTM)
234.58
Price To Sales (TTM)
14.84
Price To Book (MRQ)
17.54
Price To Cash Flow (TTM)
110.34
Total Debt To Equity (MRQ)
57.78
LT Debt To Equity (MRQ)
57.78
Return on Investment (TTM)
4.65
Return on Equity (TTM)
3.74

Latest News

Latest News

BRIEF-Straumann Acquires Majority Stake In DrSmile

* INVESTS IN DRSMILE, A LEADING PROVIDER OF CLINICIAN-LED CLEAR-ALIGNER TREATMENT SOLUTIONS IN GERMANY

BRIEF-Straumann Holding Raises A New Five-Year Straight Bond

* RAISES A FURTHER CHF 200 MILLION THROUGH SUCCESSFUL PLACEMENT OF A NEW FIVE-YEAR STRAIGHT BOND

BRIEF-Straumann CEO Says Double-Digit Growth Will Not Resume Soon At Levels Previously Forecast

* STRAUMANN HOLDING CEO SAYS JOB CUTS TO TAKE PLACE QUICKLY, TO REDUCE UNCERTAINTY; SAYS CONFIDENT OF A STRONG BOUNCEBACK WHEN CRISIS ABATES

BRIEF-Straumann Plans 9% Reduction In Workforce

* HAS BEEN GEARED FOR CONTINUING STRONG GROWTH AND ITS WORKFORCE HAS DOUBLED IN PAST THREE YEARS TO 7680

BRIEF-Straumann Withdraws Its Guidance For FY Revenue And Earnings

* STRAUMANN HOLDING AG - FIRST-QUARTER REVENUE REACHES CHF 357 MILLION, 1% OFF PRIOR-YEAR LEVEL IN ORGANIC TERMS AND -4% IN SWISS FRANCS

BRIEF-Straumann Holding Completes Placement Of CHF 280 Million Bond

* PROCEEDS FROM TRANSACTION WILL BE USED TO REFINANCE A MATURING BOND AND FOR GENERAL CORPORATE PURPOSES

Straumann says coronavirus likely to dent Asian sales

Straumann Holding <STMN.S> thinks the coronavirus outbreak could reduce its Asia-Pacific sales by more than a third at the start of 2020, the Swiss dental implant maker said on Tuesday as it reported full-year results.

BRIEF-Straumann would be very happy with double-digit sales growth rate-CEO

* STRAUMANN CEO SAYS WOULD BE VERY HAPPY TO ACHIEVE DOUBLE-DIGIT PERCENTAGE SALES GROWTH IN 2020 - WOULD MEAN TAKING SIGNIFICANT MARKET SHARE

BRIEF-Straumann Holding FY Revenue Up At CHF 1.6 Bln

* FULL-YEAR REVENUE CLIMBS 17% IN SWISS FRANCS (17% ORGANIC) TO CHF 1.6 BILLION

BRIEF-Straumann hires new R&D head away from Epredia

* SAYS MARK JOHNSON JOINS EXECUTIVE MANAGEMENT AS HEAD OF RESEARCH, DEVELOPMENT & OPERATIONS

BRIEF-Straumann Appoints Camila Finzi Appointed Head Of Orthodontics Business

* CAMILA FINZI APPOINTED HEAD OF STRAUMANN'S FAST-GROWING ORTHODONTICS BUSINESS AND MEMBER OF EXECUTIVE MANAGEMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Straumann CEO says company has resolved manufacturing issues

Straumann Holding will be in a better position to take sales from rivals next year, Chief Executive Marco Gadola said on Tuesday after the Swiss dental implant maker raised its full year guidance and beat expectations for its third quarter sales.

BRIEF-Straumann 9-month Net Revenue Of CHF 1.15 Bln

* ORGANIC1 REVENUE GROWTH REACHES 17% IN FIRST NINE MONTHS AND 19% IN Q3

BRIEF-Straumann And Modern Dental Create Joint Venture In Hong Kong And Macau

* STRAUMANN GROUP AND MODERN DENTAL GROUP JOIN FORCES TO SERVE CUSTOMERS IN HONG KONG AND MACAU

BRIEF-Straumann Makes Appointments To Executive Management

* STRAUMANN GROUP ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE MANAGEMENT TEAM

BRIEF-Straumann Will Not Explore Collaboration With Align Technology

* STRAUMANN DECIDES NOT TO EXPLORE INTRAORAL SCANNER COLLABORATION WITH ALIGN TECHNOLOGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Says Q1 Organic Revenue Growth Of 17%

* Q1 GROUP REVENUE CLIMBS 15% IN SWISS FRANCS TO CHF 372 MILLION

BRIEF-Straumann Group: 2019 AGM Approves All Proposals

* 2019 AGM APPROVES ALL PROPOSALS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Holding Raises Stake In French Implant Manufacturer Anthogyr To 100%

* STRAUMANN GROUP INCREASES STAKE IN FRENCH IMPLANT MANUFACTURER ANTHOGYR FROM 30% TO 100%.

BRIEF-Straumann Holding To Enter Clear Aligner Market In China

* EXCLUSIVE DISTRIBUTION AGREEMENT FOR CLEAR ALIGNERS DEVELOPED AND REGISTERED IN CHINA BY TIANJIN ZHENGLI TECHNOLOGY CO Source text for Eikon: Further company coverage: (Reporting by Isabela Prinz)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up